FINAL RESULTS AND PHARMACOECONOMIC ANALYSIS OF A TRIAL COMPARING TWO NEOADJUVANT CHEMOTHERAPY (CT) REGIMENS FOLLOWED BY SURGERY IN PATIENTS WITH RESECTABLE NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II RANDOMISED STUDY BY THE EUROPEAN LUNG CANCER WORKING PARTY

被引：0
|
作者：
Berghmans, Thierry
Lafitte, Jean-Jacques [1 ]
Giner, Vicente
Berchier, Marie-Claude
Scherpereel, Arnaud [1 ]
Lewin, Daniel
Paesmans, Marianne
Meert, Anne-Pascale
Bosschaerts, Thierry [2 ]
Leclercq, Nathalie
Sculier, Jean-Paul
机构：
[1] CHRU Lille, Lille, France
[2] Hop St Pierre, St Pierre, Belgium
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Non small cell lung carcinoma; Surgery; neoadjuvant chemotherapy; Cost-effectiveness;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S465 / S466
页数：2
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy followed by surgery versus upfront surgery in non-metastatic non-small cell lung cancer: systematic review and meta-analysis of randomized controlled trials
    Zhang, Xiao-Nan
    Huang, Lei
    ONCOTARGET, 2017, 8 (52) : 90327 - 90337
  • [22] Long-term results of a randomized controlled trial evaluating preoperative chemotherapy in resectable non-small cell lung cancer
    Chen, Zhiwei
    Luo, Qingquan
    Jian, Hong
    Zhou, Zhen
    Cheng, Baijun
    Lu, Shun
    Liao, Meilin
    ONCOTARGETS AND THERAPY, 2013, 6 : 645 - 650
  • [23] Phase II Trial of Neoadjuvant Therapy with Carboplatin, Gemcitabine plus Thalidomide for Stages IIB and III Non-small Cell Lung Cancer
    Dudek, Arkadiusz Z.
    Lesniewski-Kmak, Krzysztof
    Larson, Timothy
    Dragnev, Konstantin
    Isaksson, Rachel
    Gupta, Vinita
    Maddaus, Michael A.
    Kratzke, Robert A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (08) : 969 - 975
  • [24] Neoadjuvant immunotherapy combined with chemotherapy significantly improved patients' overall survival when compared with neoadjuvant chemotherapy in non-small cell lung cancer: A cohort study
    Dai, Fuqiang
    Wu, Xiaoli
    Wang, Xintian
    Li, Kunkun
    Wang, Yingjian
    Shen, Cheng
    Zhou, Jinghai
    Niu, Huijun
    Deng, Bo
    Tan, Qunyou
    Wang, Ruwen
    Guo, Wei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature
    Berghmans, T
    Paesmans, M
    Meert, AP
    Mascaux, C
    Lothaire, P
    Lafitte, JJ
    Sculier, JP
    LUNG CANCER, 2005, 49 (01) : 13 - 23
  • [26] A phase II study of neoadjuvant chemotherapy with cisplatin, epirubicin and VP-16 for stage III unresectable non-small cell lung cancer
    Iacobelli, S
    Irtelli, L
    Sacco, R
    Martino, M
    Mascitelli, E
    Basilico, L
    Scognamiglio, M
    Natoli, C
    Fusco, O
    Tinari, N
    Beltrami, V
    ANTICANCER RESEARCH, 1998, 18 (3B) : 2081 - 2084
  • [27] Long-term outcomes of neoadjuvant gefitinib in resectable stage II-IIIA non-small cell lung cancer: A phase II, prospective cohort study
    Ma, Zhanming
    Fu, Fangqiu
    Zhang, Yang
    Chen, Haiquan
    LUNG CANCER, 2025, 201
  • [28] Pathologic Response and Survival after Neoadjuvant Chemotherapy with Bevacizumab Followed by Surgery for Clinical Stage II/IIIA Nonsquamous Non-Small-Cell Lung Cancer: Results from a Phase II Feasibility Study (NAVAL)
    Tsutani, Yasuhiro
    Miyata, Yoshihiro
    Suzuki, Kenji
    Tanaka, Fumihiro
    Ito, Hiroyuki
    Yamashita, Yoshinori
    Okada, Morihito
    CANCERS, 2024, 16 (13)
  • [29] Phase II Clinical Trial of Genexol® (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer
    Kim, Han Jo
    Kim, Kyoung Ha
    Yun, Jina
    Kim, Se Hyung
    Kim, Hyun Jung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Nam Su
    Lee, Kyu Taek
    Kim, Do-Jin
    Park, Seong-Kyu
    Won, Jong-Ho
    Hong, Dae Sik
    Park, Hee Sook
    CANCER RESEARCH AND TREATMENT, 2011, 43 (01): : 19 - 23
  • [30] Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysis
    Chen, Yuqiao
    Peng, Xiong
    Zhou, Yuan
    Xia, Kun
    Zhuang, Wei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
12345